Repeat Cytoreduction with Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Disease: A 5-Year Retrospective Analysis
2024; Elsevier BV; Volume: 54; Linguagem: Inglês
10.1016/j.suronc.2024.102078
ISSN1879-3320
AutoresJoão Mendes, Sónia Marques, Mariana Peyroteo, Mercês Lobo, Fernanda Sousa, Manuel Fernandes, José Flávio Videira, Abreu de Sousa,
Tópico(s)Hernia repair and management
ResumoCytoreductive surgery with Hyperthermic Intraperitoneal Chemotherapy (CR-HIPEC) is a locorregional surgical therapy applied in patients with peritoneal-only metastatic disease of primary abdominal malignancies. Integrated in a multimodal treatment, CR-HIPEC is associated with increased overall survival. In cases of peritoneal-site only relapse, it may be carried out more than once.
Referência(s)